For instance, probiotics and synbiotics have shown efficacy in lowering pro-inflammatory cytokines in prediabetes and type 2 diabetes, with a 2023 randomized trial demonstrating significant IL-6 and TNF-α reductions over 12 weeks [28]. Here, IL6 is linked to prediabetes syndrome.